IE000B9PQW54
IE000B9PQW54
VanEck Genomics and Healthcare Innovators UCITS ETF
Loading chart...
Analytics & Allocation
Detailed breakdown by growth drivers, valuation & quality, and asset allocation
Growth Drivers (Estimates)
Largest contributors to earnings and revenue growth
Sectors & Industries
Weight
Avg. Growth
Contribution
Balance Sheet & Financial Health
Aggregated leverage and valuation structure
Weighted P/E
28.87
Weighted Fwd P/E
70.78
Avg P/FCF
46.67
Avg FCF Yield
1.26%
Avg EV / EBITDA
50.89
Avg EV / Revenue
26.42
Avg Price-to-Book (P/B)
15.03
Avg Price-to-Sales (P/S)
31.79
Avg Dividend Yield
0.00%
P/E Compression (Trailing vs Fwd)
+145.13%
Avg Debt-to-Equity (D/E)
59.24%
<50% (66.1%) 50-150% (17.09%) >150% (10.87%) Unreported (5.94%)
Profitability Analysis
49 Holdings CountProfitable 63.66%
Profitable 63.66%
34
Holdings Count (69.39%)
Unprofitable 36.34%
15
Holdings Count (30.61%)
ETF Concentration (Cumulative Weight)
Cumulative weight of positions (Lorenz curve)
Top 5
36.6%
Top 10
60.0%
Top 25
86.3%
50% Threshold
Top 8
The top 10 holdings account for 60% of the total ETF. Performance is heavily driven by a few heavyweights. The steeper the curve initially rises, the more the largest positions dominate the fund volume.
Geographic Distribution
11 CountriesLoading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (20.7%+)
High (53.9%+)
Top (74.6%+)
Country Breakdown
Max: 82.86%
US US82.86%
DE DE3.71%
HK HK2.74%
NL NL2.72%
AU AU1.74%
CN CN1.71%
CH CH1.32%
JP JP1.26%
SE SE1.06%
GB GB0.57%
BE BE0.32%
Sector Distribution
1 SectorIndustry Distribution
7 IndustriesMarket Cap Distribution
49 Holdings CountLarge Cap (10B - 200B)
(13) 65.52%
Mid Cap (2B - 10B)
(23) 29.93%
Small / Micro Cap (< 2B)
(13) 4.56%